未登录

G

Guoliang Qing

Zhongnan Hospital of Wuhan University

H指数:35

被引数:5,633

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Oncogenic DHX15 mutation enhances mitochondrial metabolism and sustains leukemia stemness

致癌性DHX15突变增强线粒体代谢并维持白血病干性

IF13.4

2026-08-210

PRE

CDK10 suppresses nucleic acid sensors-mediated antitumor immunity

CDK10抑制核酸传感器介导的抗肿瘤免疫

IF28.5

2026-01-080

PRE

Destruction of VISTA by TRIM25 ablation in T cells potentiates cancer immunotherapy

TRIM25在T细胞中的缺失导致VISTA的破坏，增强了癌症免疫治疗的效果。

IF25.9

2025-11-130

PRE

Therapeutic targeting nudix hydrolase 1 creates a MYC-driven metabolic vulnerability

NATURE COMMUNICATIONS

IF15.7

2024-03-161

OAAI

HILPS, a long noncoding RNA essential for global oxygen sensing in humans

SCIENCE ADVANCES

IF12.5

2023-11-241

OAAI

The super elongation complex drives transcriptional addiction in MYCN-amplified neuroblastoma

SCIENCE ADVANCES

IF12.5

2023-03-317

OAAI

MYC Degradation under Low O2 Tension Promotes Survival by Evading Hypoxia-Induced Cell Death

MOLECULAR AND CELLULAR BIOLOGY

IF2.7

2023-03-2041

OAAI

CDK13 phosphorylates the translation machinery and promotes tumorigenic protein synthesis

IF7.3

2023-03-076

PRE

RNA helicase DHX15 exemplifies a unique dependency in acute leukemia

IF7.9

2023-03-026

OAAI

EZH2 depletion potentiates MYC degradation inhibiting neuroblastoma and small cell carcinoma tumor formation

EZH2耗竭增强MYC降解抑制神经母细胞瘤和小细胞癌肿瘤形成

NATURE COMMUNICATIONS

IF15.7

2022-01-1063

OAAI

USP29 coordinates MYC and HIF1α stabilization to promote tumor metabolism and progression

IF7.3

2021-10-0224

PREAI

Crosstalk between oncogenic MYC and noncoding RNAs in cancer

SEMINARS IN CANCER BIOLOGY

IF15.7

2021-10-019

PREAI

Metabolic Enzyme DLST Promotes Tumor Aggression and Reveals a Vulnerability to OXPHOS Inhibition in High-Risk Neuroblastoma

CANCER RESEARCH

IF16.6

2021-07-0736

OA

Synergistic targeting of CHK1 and mTOR in MYC-driven tumors

IF2.9

2020-11-1813

PREAI

WEE1 inhibition induces glutamine addiction in T-cell acute lymphoblastic leukemia

IF7.9

2020-01-0924

OAAI

FDA-approved drug screen identifies proteasome as a synthetic lethal target in MYC-driven neuroblastoma

IF7.3

2019-08-1227

PREAI

SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival

NATURE COMMUNICATIONS

IF15.7

2018-10-1526

OAAI

Targeting oncogenic Myc as a strategy for cancer treatment

靶向致癌Myc作为癌症治疗策略

Signal Transduction and Targeted Therapy

IF52.7

2018-02-230

OAAI

Oncogenic MYC Activates a Feedforward Regulatory Loop Promoting Essential Amino Acid Metabolism and Tumorigenesis

致癌性MYC激活促进必需氨基酸代谢和肿瘤发生的前馈调节回路

IF6.9

2017-12-01162

OAAI

Integrated genomic analysis identifies deregulated JAK/STAT-MYC-biosynthesis axis in aggressive NK-cell leukemia

IF25.9

2017-11-1765

OA

Huang, Liang; Liu, Dan; Wang, Na; Ling, Shaoping; Tang, Yuting; Wu, Jun; Hao, Lingtong; Luo, Hui; Hu, Xuelian; Sheng, Lingshuang; Zhu, Lijun; Wang, Di; Luo, Yi; Shang, Zhen; Xiao, Min; Mao, Xia; Zhou, Kuangguo; Cao, Lihua; Dong, Lili; Zheng, Xinchang; Sui, Pinpin; He, Jianlin; Mo, Shanlan; Yan, Jin; Ao, Qilin; Qiu, Lugui; Zhou, Hongsheng; Liu, Qifa; Zhang, Hongyu; Li, Jianyong; Jin, Jie; Fu, Li; Zhao, Weili; Chen, Jieping; Du, Xin; Qing, Guoliang; Liu, Hudan; Liu, Xin; Huang, Gang; Ma, Ding; Zhou, Jianfeng; Wang, Qian-fei